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methods. In contrast, the incidence of ASC-US (atypical squa-
mous cells of undetermined significance) was almost twice 
as frequent between LBC and conventional smears, at 2.9 
versus 1.6%, respectively. An equal percentage of high-
grade squamous intraepithelial lesions were observed for 
the two methods, but not for low-grade squamous intraepi-
thelial lesions, which were more significantly observed in 
LBC preparations than in conventional smears (2.2 vs. 0.7%). 
The index of positivity was importantly enhanced from 3.0% 
(conventional smears) to 5.7% (LBC).  Conclusions : LBC per-
formed better than conventional smears, and we are truly 
confident that LBC can improve public health strategies 
aimed at reducing cervical lesions through prevention pro-
grams.  © 2015 S. Karger AG, Basel 
 Introduction 
 The introduction of the Papanicolaou test (Pap test) 
proved to be effective in reducing mortality caused by cer-
vical cancer in developed countries. Unfortunately, cervi-
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 Abstract 
 Objective: The aim of this study was to compare the perfor-
mance of the current conventional Pap smear with liquid-
based cytology (LBC) preparations.  Study Design: Women 
routinely undergoing their cytopathological and histopath-
ological examinations at Fundação Oncocentro de São Pau-
lo (FOSP) were recruited for LBC. Conventional smears were 
analyzed from women from other areas of the State of São 
Paulo with similar sociodemographic characteristics.  Re-
sults: A total of 218,594 cases were analyzed, consisting of 
206,999 conventional smears and 11,595 LBC. Among the 
conventional smears, 3.0% were of unsatisfactory prepara-
tion; conversely, unsatisfactory LBC preparations accounted 
for 0.3%. The ASC-H (atypical squamous cells – cannot ex-
clude high-grade squamous intraepithelial lesion) frequen-
cy did not demonstrate any differences between the two 
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cal cancer still represents a serious public health problem 
in poor and developing countries, including Brazil  [1, 2] , 
where this neoplasia remains very frequent, with about 
16,000 new cases per year  [3] . Worldwide, the Pap test is 
still used by the majority of cervical cancer screening pro-
grams as the primary laboratorial tool of prevention. The 
conventional Pap smear has a winning history on de-
creasing the incidence of and mortality from cervical can-
cer, with an estimated reduction of around 80%, but this 
is restricted to settings with high-quality cytology screen-
ing that is effectively and regularly executed, with a good 
population coverage  [4] . The conventional Pap smear, 
however, is quite laborious, with various difficulties con-
cerning collection, the preparation of glass slides and 
reading. On the other hand, Pap tests prepared with col-
lection in liquid medium result in homogeneous prepara-
tions that facilitate reading and enable a better perfor-
mance by cytotechnologists, significantly reducing the 
proportion of unsatisfactory smears, and allowing read-
ings through an automated system  [5] . Liquid-based cy-
tology (LBC), besides representing the technical develop-
ment of conventional cytology, also offers a single means 
of collecting samples that preserves nucleic acids and al-
lows the transport and storage of samples at room tem-
perature, and is quite suitable for screening algorithms 
that include human papillomavirus (HPV) testing  [6, 7] . 
For over a decade, strong evidence indicating that Pap 
smears collected in liquid medium have a sensitivity and 
specificity similar to those of conventional cytology has 
been presented  [8] . In addition, a number of recent pub-
lications have clearly demonstrated that LBC offers in-
creased indexes of cytology positivity, and a consistent 
and remarkable reduction of unsatisfactory preparations 
 [9–12] . Moreover, the best performance can be achieved 
with the use of computer-assisted screening programs, 
which is also feasible but not frequently employed glob-
ally with conventional Pap smears  [13] . The São Paulo 
State Secretary of Health (SES) is responsible for the col-
lection and analysis of approximately 2.5 million Pap tests 
per year, and the Fundação Oncocentro de São Paulo – 
FOSP (with the third-largest volume) performs about 
250,000 of these tests. Under this scenario, molecular 
techniques could favor cervical cancer screening because 
of its very high negative predictive value (>99%) and high 
sensitivity  [14] . Data from the Hospital Cancer Registry 
of the FOSP show that the proportion of women under 30 
years of age with invasive cervical cancer is small. Be-
tween January 2000 and April 2012, 13,760 invasive cervi-
cal cancer cases were accounted for in the State of São 
Paulo, of which 436 (3.2%) occurred in women between 
the age of 25 and 29 years, and 122 (0.9%) cases were in 
women aged between 20 and 24 years. The comparison of 
cervical cancer survival rates indicates a huge difference 
among developed and underserved countries, attribut-
able to differences in access to early diagnosis, quality of 
screening and the existence or lack of programs of screen-
ing, as well as the provision of adequate treatment  [15–
17] . This study aimed to evaluate the preliminary results 
of the introduction of LBC to the daily routine of Pap tests
analyzed in the FOSP laboratory, and to compare results 
with conventional Pap smears performed over the same 
period.
 Material and Methods 
 The samples for this study were collected from women partici-
pating in the Projeto Região Oeste of the Health Care Facilities 
opportunistic program: Basic Health Units (supported by Facul-
dade de medicina da Universidade São Paulo – FMUSP) and the 
Interlagos Hospital and Maternity Center, from December 2013 to 
December 2014. The target population was women of any age that 
spontaneously visited the Public Health Ambulatories associated 
to the FOSP. The conventional Pap smears were collected from 
several ambulatories distributed in São Paulo State with similar 
sociodemographic characteristics to those where LBC was intro-
duced. The comparison of the performance of both methodologies 
was made by evaluating the overall results of each during the pe-
riod of study. The Ethics Committee of the Faculty of Medicine, 
University of São Paulo, approved this study (No. 075/13).
 For the liquid-based Pap test cells were collected from the en-
doectocervical junction and placed in the recipient containing the 
liquid fixer. The whole brush head was placed in the recipient con-
taining BD SurePath TM (BD Diagnostics – TriPath, Burlington, 
N.C., USA) liquid and sent to the FOSP laboratory for the prepara-
tion of glass slides according to manufacturer’s instructions using 
the semiautomated BD PrepMate TM and BD PrepStain TM (BD Di-
agnostics – TriPath) tools. Before starting the study, the FOSP 
team received training in the preanalytical phase of cytological and 
molecular examinations, as well as in the LBC reading. 
 Results 
 A total of 218,594 cases were analyzed: 206,999 con-
ventional smears and 11,595 LBC preparations.  Table 1 
shows the number of women analyzed by each test ac-
cording to age. Among the conventional smears, 3.0% 
were unsatisfactory preparations, which corresponds to 
6,239 cases; conversely, unsatisfactory LBC preparations 
accounted for 0.3%, or 29 cases, predominantly repre-
sented by samples collected from atrophic cervices ( ta-
ble 2 ).  Table 3 shows the distribution of cytological results 
between the preparations performed with liquid medium 
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and conventional methodologies. Of note, there was no 
difference in ASC-H (atypical squamous cells – cannot 
exclude high-grade squamous intraepithelial lesion) be-
tween the two methods. In contrast, ASC-US (atypical 
squamous cells of undetermined significance) was re-
corded in almost twice as many LBC cases as in conven-
tional smears – 2.9 versus 1.6%, respectively. An equal 
percentage of high-grade squamous intraepithelial lesion 
(HSIL) was observed for the two methods, but not for 
low-grade squamous intraepithelial lesion (LSIL), which 
was more frequently observed in LBC preparations than 
in conventional smears (2.2 vs. 0.7%). Invasive carcinoma 
was detected in 1 case prepared with LBC technology and 
in 20 conventional smear cases, which proportionally was 
very similar, with no perceived differences between the 
two methods. The index of positivity was considerably 
enhanced (p < 0.0001) from 3.0% (conventional smears) 
to 5.7% (LBC). Finally,  table 4 shows the distribution of 
endocervical representation in both preparations. No dif-
ferences were observed between either methodology, 
which implies, in part, a similar performance of sample 
collection. 
 Discussion 
 The results achieved in this study are very encouraging 
because the index of positive results for the conventional 
smears compared to LBC preparations rose from 3.0 to 
5.7%, almost doubling the number of cases, representing 
a significant impact for public health cervical cancer 
strategies. São Paulo State has more than 40 million in-
 Table 1.  Number of women analyzed by each test according to age
Age distribution,
years
 Cytology preparation
LBC, n (%) conventional, n (%)
11 – 24 1,523 (13.1) 30,957 (15.0)
25 – 44 5,040 (43.5) 92,285 (44.6)
45 – 64 4,075 (35.1) 71,609 (34.6)
65+ 957 (8.3) 12,148 (5.9)
Total 11,595 (100.0) 206,999 (100.0)
 Table 2.  Number of unsatisfactory and satisfactory preparations 
performed with liquid medium and conventional methodologies
Sample adequacy  Cytology preparation
LBC, n (%) conventional, n (%)
Unsatisfactory 29 (0.3) 6,239 (3.0)
Satisfactory 11,566 (99.7) 200,760 (97.0)
Total 11.595 (100.0) 206.999 (100.0)
Cytological result  Cytology preparation Total, n (%)
LBC, n (%) conventional, n (%)
ASC-H 43 (0.4) 1,007 (0.5) 1,050 (0.5)
ASC-US 337 (2.9) 3,253 (1.6) 3,590 (1.6)
Invasive carcinoma 1 (0.0) 19 (0.0) 20 (0.0)
HSIL 18 (0.2) 419 (0.2) 437 (0.2)
LSIL 256 (2.2) 1,427 (0.7) 1,683 (0.8)
Negative 10,940 (94.4) 200,874 (97.0) 211,814 (96.9)
Total 11,595 (100.0) 206,999 (100.0) 218,594 (100.0)
 Table 3.  Distribution of cytological results 
between the preparations performed with 
liquid medium and conventional 
methodologies
Endocervical
cells detection
 Cytology preparation Total, n (%)
LBC, n (%) conventional, n (%)
Yes 6,575 (56.7) 120,162 (58.0) 126,737 (58.0)
No 5,023 (43.3) 86,913 (42.0) 91,936 (42.0)
Total 11,598 (100.0) 207,075 (100.0) 218,673 (100.0)
 Table 4.  Distribution of endocervical 
representation by LBC and conventional 
methodologies
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habitants, and FOSP represents an important institution 
for cancer registration, training of public health profes-
sionals, and quality control of cytopathology procedures. 
The frequencies of squamous columnar junction in both 
methodologies were similar. The accuracy of sample col-
lection probably influenced the results we observed. It is 
important to note, for example, that the frequencies of 
positive HSIL were similar by both methodologies, and 
no important gain was detected with the introduction of 
LBC, as has been anticipated in other studies  [9, 18] . The 
same proportion of invasive cancers was obtained with 
both methodologies. However, for settings with an elevat-
ed prevalence of high-grade lesions, LBC is proven to be 
more effective for detecting HSIL than conventional 
smears  [10–12] . We hypothesize that these promising re-
sults would be even more relevant if LBC was applied in 
a large casuistic population. Importantly, the remarkable 
increase of LSIL exceeded our expectations. LSIL altera-
tions were significantly more frequent in LBC samples 
than conventional preparations, which endorsed the ob-
servations reported in many previous studies  [9, 19, 20] . 
LSIL is recognized as a reversible/transitory lesion; how-
ever, the impact of the augmented frequency of LSIL 
might signify an increase of HSIL after colposcopic ex-
amination if LSIL persists  [21] . This fact is particularly 
evident if high-risk HPV tests are judiciously applied in 
LSIL cases; the LSIL result combined with a positive high-
risk HPV test is strongly associated to a high-grade lesion 
on biopsy  [21] . This evidence encouraged us to continue 
our research and initiate a project that involves the com-
bination of LBC, slide reading preparation and automa-
tion, and HPV testing, which will be implemented in the 
near future. Moreover, LBC plus a HPV DNA test detects 
more high-grade lesions and avoids many abnormal cy-
tology results without a clinically significant increase in 
the number of unnecessary colposcopies  [21] . 
 One of the most remarkable results we achieved relates 
to the adequacy of cytological samples. The FOSP labora-
tory performs more than 200,000 Pap tests annually. The 
proportion of unsatisfactory cases was very high in con-
ventional smears, totaling more than 6,000 cases. If one 
considers that the Brazilian Government funds more 
than 10 million PAP tests each year with the aim of pre-
vention, 3% represents approximately 300,000 women to 
be recalled. However, the indexes of unsatisfactory cases 
in Brazil prompt far less optimism than we found in the 
FOSP laboratory; not surprisingly, robust evidence indi-
cates that in most settings reflex HPV triage is likely to be 
the optimal strategy for managing women presenting 
with ASC-US results  [22] . The higher number of positive 
cases in the LBC arm was also associated with the aug-
mented number of ASC-US. This is not surprising, and 
the higher frequency of ASC-US in LBC is related to the 
‘learning curve’ period that can vary among cytotechnol-
ogists, dependent on their particular skills. The LBC 
preparation-associated ASC-US frequency tends to de-
crease over time and establish a slight superior baseline as 
compared with conventional smears  [12] . Moreover, sig-
nificant improvements are expected in accomplishing the 
correct diagnosis over time for intraepithelial lesions 
 [23] . 
 Finally, LBC offers an opportunity to introduce a high 
level of internal quality assurance in cytological diagnoses 
with a reproducible use of computer-guided image 
screening  [24] that potentially reduces the margin of 
false-negative results and enhances the sensitivity of the 
Pap test evaluation  [25] , besides permitting the imple-
mentation of combined analyses of cytology and HPV 
molecular tests  [26] . It is important to mention that be-
tween 2009 and 2011 the National Institute of Science and 
Technology of the Diseases Associated to the Papilloma-
virus (INCT-HPV) performed an assessment study of 
molecular techniques and proposed new algorithms for 
cervical cancer screening, which showed a very high neg-
ative predictive value (>99%) and high sensitivity  [14] . 
Currently, the INCT-HPV is engaged with FOSP to initi-
ate projects towards screening improvements. Our stan-
dards of positivity are comparable to the best-practice 
laboratories in cytopathology. In the near future, we are 
planning to improve our efforts in cervical cancer preven-
tion with the combination of HPV testing and cytology 
automation. 
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